RT Journal Article
SR Electronic
T1 Qualitative forecast and temporal evolution of the disease spreading using a simplified model and COVID-19 data for Italy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.22.20137133
DO 10.1101/2020.06.22.20137133
A1 Simeone, Roberto
YR 2020
UL http://medrxiv.org/content/early/2020/09/26/2020.06.22.20137133.abstract
AB In a previous paper [1] a simplified SEIR model applied to COVID-19 cases detected in Italy, including the lockdown period, has shown a good fitting to the time evolution of the disease during the observed period.In this paper that model is applied to the initial data available for Italy in order to forecast, in a qualitative way, the time evolution of the disease spreading. The values obtained are to be considered indicative.The same model has been applied both to the data relating to Italy and to some italian regions generally finding good qualitative results.The only tuning parameter in the model is the ‘incubation period’ τ.In this modelization the tuning parameter, together with the calculated growth rate of the exponential curve used to approximate the early stage data, are in strong relationship with the compartments’ transfer rates.The relationships between the parameters simplify modeling by allowing a rough (not supported by statistical considerations) forecast of the time evolution, starting from the first period of growth of the diffusion.Conclusions A simplified compartmental model that uses only the incubation period and the exponential growth rate as parameters is applied to the COVID-19 data for Italy in several periods of the initial growth of the diffusion showing the different stages of the spread evolution. The simplification is based on the strong protection measures that were in place in Italy during the lockdown period after the initial free diffusion.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPersonal research, no funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Personal research, no IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe dataset used in the manuscript is publicly available on the websites managed by italian Dipartimento della Protezione Civile. https://github.com/pcm-dpc/COVID-19/blob/master/dati-regioni/dpc-covid19-ita-regioni.csv http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1